August 23, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, August 2021

Fall 2021 Group Meeting to be virtual; a new prevention trial; the case for COVID-19 vaccination
August 17, 2021
Green tea catechin pills

Now Enrolling: EA8184 for Prostate Cancer

This phase II study is testing the effects and safety of green tea catechins (GTC) as a chemopreventive agent
August 17, 2021
Doctor talking with patient

Now Enrolling: EAA171/OPTIMUM for Myeloma

This randomized phase III trial aims to determine if the addition of ixazomib to lenalidomide improves overall survival in patients with multiple myeloma
August 17, 2021
Patient getting imaging

EA2185 Pancreatic Cyst Surveillance Study: Amendment #2 Highlights

This study is evaluating two different screening strategies for non-cancerous pancreatic cysts; recently activated amendment #2 expands the eligibility criteria
August 17, 2021
Doctor examining patient's neck

Trial Spotlight: Dan Zandberg on the EA3191 Study for Head and Neck Squamous Cell Carcinoma

This phase II trial is comparing adjuvant treatment with either reirradiation plus pembrolizumab, pembrolizumab monotherapy, or reirradiation with platinum chemotherapy
August 17, 2021
Montefiore exterior shot

Institution Spotlight: Montefiore Health System and Albert Einstein Cancer Center

A Standing Main Member of ECOG-ACRIN since 1972
August 17, 2021
News in Brief

News in Brief, August 2021